NUS Relative Valuation
NUS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NUS is overvalued; if below, it's undervalued.
Historical Valuation
NU Skin Enterprises Inc (NUS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 7.34 is considered Undervalued compared with the five-year average of 12.23. The fair price of NU Skin Enterprises Inc (NUS) is between 10.89 to 21.12 according to relative valuation methord. Compared to the current price of 10.32 USD , NU Skin Enterprises Inc is Undervalued By 5.24%.
Relative Value
Fair Zone
10.89-21.12
Current Price：10.32
5.24%
Undervalued
7.34
PE
1Y
3Y
5Y
0.00
EV/EBITDA
NU Skin Enterprises Inc. (NUS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 6.11. The thresholds are as follows: Strongly Undervalued below 0.35, Undervalued between 0.35 and 3.23, Fairly Valued between 8.99 and 3.23, Overvalued between 8.99 and 11.87, and Strongly Overvalued above 11.87. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
4.50
EV/EBIT
NU Skin Enterprises Inc. (NUS) has a current EV/EBIT of 4.50. The 5-year average EV/EBIT is 9.70. The thresholds are as follows: Strongly Undervalued below 3.75, Undervalued between 3.75 and 6.73, Fairly Valued between 12.68 and 6.73, Overvalued between 12.68 and 15.66, and Strongly Overvalued above 15.66. The current Forward EV/EBIT of 4.50 falls within the Undervalued range.
0.31
PS
NU Skin Enterprises Inc. (NUS) has a current PS of 0.31. The 5-year average PS is 0.64. The thresholds are as follows: Strongly Undervalued below -0.04, Undervalued between -0.04 and 0.30, Fairly Valued between 0.98 and 0.30, Overvalued between 0.98 and 1.32, and Strongly Overvalued above 1.32. The current Forward PS of 0.31 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
NU Skin Enterprises Inc. (NUS) has a current P/OCF of 0.00. The 5-year average P/OCF is 8.07. The thresholds are as follows: Strongly Undervalued below -2.98, Undervalued between -2.98 and 2.55, Fairly Valued between 13.59 and 2.55, Overvalued between 13.59 and 19.11, and Strongly Overvalued above 19.11. The current Forward P/OCF of 0.00 falls within the Undervalued range.
0.00
P/FCF
NU Skin Enterprises Inc. (NUS) has a current P/FCF of 0.00. The 5-year average P/FCF is 18.02. The thresholds are as follows: Strongly Undervalued below -12.55, Undervalued between -12.55 and 2.73, Fairly Valued between 33.30 and 2.73, Overvalued between 33.30 and 48.59, and Strongly Overvalued above 48.59. The current Forward P/FCF of 0.00 falls within the Undervalued range.
NU Skin Enterprises Inc (NUS) has a current Price-to-Book (P/B) ratio of 0.59. Compared to its 3-year average P/B ratio of 1.00 , the current P/B ratio is approximately -40.72% higher. Relative to its 5-year average P/B ratio of 1.67, the current P/B ratio is about -64.28% higher. NU Skin Enterprises Inc (NUS) has a Forward Free Cash Flow (FCF) yield of approximately 11.29%. Compared to its 3-year average FCF yield of 12.06%, the current FCF yield is approximately -6.33% lower. Relative to its 5-year average FCF yield of 9.63% , the current FCF yield is about 17.30% lower.
0.59
P/B
Median3y
1.00
Median5y
1.67
11.29
FCF Yield
Median3y
12.06
Median5y
9.63
Competitors Valuation Multiple
The average P/S ratio for NUS's competitors is 0.37, providing a benchmark for relative valuation. NU Skin Enterprises Inc Corp (NUS) exhibits a P/S ratio of 0.31, which is -14.98% above the industry average. Given its robust revenue growth of -15.33%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NUS increased by 55.12% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 1.93 to 4.69.
The secondary factor is the Revenue Growth, contributed -15.33%to the performance.
Overall, the performance of NUS in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
TBRG
TruBridge Inc
22.7USD
4.51%
FRBA
FIRST BANK (Hamilton)
16.75USD
2.57%
KRRO
Korro Bio Inc
9.15USD
7.77%
EB
Eventbrite Inc
4.46USD
0.00%
GLUE
Monte Rosa Therapeutics Inc
25.31USD
8.72%
BARK
Bark Inc
0.5647USD
4.63%
IHRT
iHeartMedia Inc
3.98USD
1.79%
LOCO
El Pollo Loco Holdings Inc
10.95USD
2.15%
NEWT
NewtekOne Inc
12.63USD
5.87%
RR
Richtech Robotics Inc
3.93USD
14.91%
Frequently Asked Questions
Is NU Skin Enterprises Inc (NUS) currently overvalued or undervalued?
NU Skin Enterprises Inc (NUS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 7.34 is considered Undervalued compared with the five-year average of 12.23. The fair price of NU Skin Enterprises Inc (NUS) is between 10.89 to 21.12 according to relative valuation methord. Compared to the current price of 10.32 USD , NU Skin Enterprises Inc is Undervalued By 5.24% .
What is NU Skin Enterprises Inc (NUS) fair value?
NUS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of NU Skin Enterprises Inc (NUS) is between 10.89 to 21.12 according to relative valuation methord.
How does NUS's valuation metrics compare to the industry average?
The average P/S ratio for NUS's competitors is 0.37, providing a benchmark for relative valuation. NU Skin Enterprises Inc Corp (NUS) exhibits a P/S ratio of 0.31, which is -14.98% above the industry average. Given its robust revenue growth of -15.33%, this premium appears unsustainable.
What is the current P/B ratio for NU Skin Enterprises Inc (NUS) as of Jan 09 2026?
As of Jan 09 2026, NU Skin Enterprises Inc (NUS) has a P/B ratio of 0.59. This indicates that the market values NUS at 0.59 times its book value.
What is the current FCF Yield for NU Skin Enterprises Inc (NUS) as of Jan 09 2026?
As of Jan 09 2026, NU Skin Enterprises Inc (NUS) has a FCF Yield of 11.29%. This means that for every dollar of NU Skin Enterprises Inc’s market capitalization, the company generates 11.29 cents in free cash flow.
What is the current Forward P/E ratio for NU Skin Enterprises Inc (NUS) as of Jan 09 2026?
As of Jan 09 2026, NU Skin Enterprises Inc (NUS) has a Forward P/E ratio of 7.34. This means the market is willing to pay $7.34 for every dollar of NU Skin Enterprises Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for NU Skin Enterprises Inc (NUS) as of Jan 09 2026?
As of Jan 09 2026, NU Skin Enterprises Inc (NUS) has a Forward P/S ratio of 0.31. This means the market is valuing NUS at $0.31 for every dollar of expected revenue over the next 12 months.